CCN2 and central nervous system cancer: It was shown that miR-375 might be able to inhibit glioma growth by repressing the Cellular Communication Network factor 2 (CCN2 or CTGF)-epidermal growth factor receptor signaling pathway, resulting in the reduction of glioma proliferation, migration and invasion [86].